Journal List > Pediatr Infect Vaccine > v.26(2) > 1130683

Lim, Lee, Jung, and Oh: Research Areas and Trends in Articles on Pediatric and Adolescent Tuberculosis in Korea

Abstract

Purpose

Despite the decline in tuberculosis (TB) incidence and mortality rates in the Republic of Korea through a national TB control program, TB remains one of the most critical infectious diseases in Korean children. We investigated the trends and research areas of published articles on TB in Korean children and adolescents.

Methods

In 6 Korean and overseas databases, we searched titles and abstracts including “tuberculo∗” or “TB,” “child∗” or “adolescen∗” or “neonat∗” or “infant∗” or “pediatric∗,” and “korea∗.” The publication type, publication year, research areas, journal title, and research subjects were analyzed.

Results

Out of the 257 searched documents, 120 papers were included in the analysis. Of these, 82 were original articles (68.3%), 33 case reports (27.5%), 4 review articles (3.3%), and 1 guideline (0.8%). In the original articles, the most common subject of studies was the clinical characteristics of patients with TB (36.6%), followed by diagnostics (29.3%), contact investigations (9.8%), epidemiology (6.1%), treatment (4.9%), vaccine (3.6%), latent TB infection (3.6%), complications (3.6%), and surveys on perception of TB (2.4%). From 1962, 4 articles were published in the 1960s, 10 articles in the 1970s, 11 articles in the 1980s, 22 articles in the 1990s, 26 articles in the 2000s, and 47 articles since 2010.

Conclusions

The amount of research on TB in Korean children has increased over the past 5 decades; however, it has mainly focused on the clinical characteristics and diagnostics. Research in different areas, such as treatment and vaccine, is needed in the future.

References

1. World Health Organization. Global tuberculosis report: exclusive summary [Internet]. Geneva: World Health Organization;2018. [cited 2019 Mar 21]. Available from:. https://www.who.int/tb/publications/global_report/tb18_ExecSum_web_4Oct18.pdf.
2. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012; 367:348–61.
crossref
3. World Health Organization. Roadmap for childhood tuberculosis: towards zero deaths [Internet]. Geneva: World Health Organization;2013. [cited 2019 Mar 21]. Available from:. https://apps.who.int/iris/bitstream/han-dle/10665/89506/9789241506137_eng.pdf.
4. Cho KS. Tuberculosis control in the Republic of Korea. Epidemiol Health. 2018; 40:e2018036.
crossref
5. Stop TB Partnership; World Health Organization. An international roadmap for tuberculosis research: towards a world free of tuberculosis [Internet]. Geneva: World Health Organization;2011. [cited 2019 Mar 21]. Available from:. http://www.stoptb.org/assets/documents/resources/publications/technical/tbresearchroadmap.pdf.
6. Kang PS, Lee SK. A study on the effects of BCG vaccination against tuberculosis. Korean J Prev Med. 1982; 15:33–46.
7. Lee H, Cho SN, Kim HJ, Anh YM, Choi JE, Kim CH, et al. Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea. Vaccine. 2011; 29:6564–71.
crossref
8. Lee H, Dockrell HM, Kim DR, Floyd S, Oh SY, Lee JB, et al. The current status of BCG vaccination in young children in South Korea. Tuberc Respir Dis (Seoul). 2012; 72:374–80.
crossref
9. Schrager LK, Harris RC, Vekemans J. Research and development of new tuberculosis vaccines: a review. F1000Res. 2018; 7:1732.
crossref
10. Loxton AG, Knaul JK, Grode L, Gutschmidt A, Meller C, Eisele B, et al. Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa. Clin Vaccine Immunol. 2017; 24:e00439–16.
crossref
11. Scott KM, Lee HK, Ham SS, Park SO, Kim HD, Koh WH, et al. A study of household contacts of cases with pulmonary tuberculosis. Yonsei Med J. 1962; 3:74–8. CROSSREF.
crossref
12. Medical Research Council Working Party. A controlled trial of plaster-of-paris jackets in the management of ambulant outpatient treatment of tuberculosis of the spine in children on standard chemotherapy. A study in Pusan, Korea. Second report of the Medical Research Council Working Party on Tuberculosis of the Spine. Tubercle. 1973; 54:261–82.
13. Oh HJ, Yoon HS, Bynn HS, Huh KY, Sohn C. Effects of rifampin (RMP) on liver function in tuberculous children. J Korean Pediatr Soc. 1981; 24:430–6.
14. Lee KS, Park KC, Shin MJ, Kang SC. Rifampin effects on tuberculous meningitis in children. J Korean Pediatr Soc. 1978; 21:543–51.
15. Stop TB Department; Department of Child and Adolescent Health and Development of the World Health Organization. A research agenda for childhood tuberculosis [Internet]. Geneva: World Health Organization;2007. [cited 2019 Mar 22]. Available from:. https://apps.who.int/iris/bitstream/handle/10665/69611/WHO_HTM_TB_2007.381_eng.pdf.
16. Child & Adolescent TB Working Group. Research priorities for paediatric tuberculosis [Internet]. New York, NY: Treatment Action Group;2018. [cited 2019 Mar 22]. Available from:. https://www.finddx.org/wp-content/uploads/2018/09/Paediatric_TB_ResearchPriorities_FINAL_Web.pdf.
17. Bekker A, Schaaf HS, Draper HR, van der Laan L, Murray S, Wiesner L, et al. Pharmacokinetics of rifampin, isoniazid, pyrazinamide, and ethambutol in infants dosed according to revised WHO-recommended treatment guidelines. Antimicrob Agents Chemother. 2016; 60:2171–9.
crossref
18. Denti P, Garcia-Prats AJ, Draper HR, Wiesner L, Winckler J, Thee S, et al. Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis. Antimicrob Agents Chemother. 2018; 62:e01521–17.
crossref
19. McIlleron H, Hundt H, Smythe W, Bekker A, Winckler J, van der Laan L, et al. Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes. Int J Tuberc Lung Dis. 2016; 20:915–9.
crossref
20. Garcia-Prats AJ, Draper HR, Finlayson H, Winckler J, Burger A, Fourie B, et al. Clinical and cardiac safety of longterm levofloxacin in children treated for multidrug-resistant tuberculosis. Clin Infect Dis. 2018; 67:1777–80.
crossref
22. Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis. 2010; 50(Suppl 3):S184–94.
crossref
23. Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis. 2012; 55:1088–95.
crossref
24. Marcy O, Ung V, Goyet S, Borand L, Msellati P, Tejiokem M, et al. Performance of Xpert MTB/RIF and alternative specimen collection methods for the diagnosis of tuberculosis in HIV-infected children. Clin Infect Dis. 2016; 62:1161–8.
crossref
25. Walters E, van der Zalm MM, Palmer M, Bosch C, Demers AM, Draper H, et al. Xpert MTB/RIF on stool is useful for the rapid diagnosis of tuberculosis in young children with severe pulmonary disease. Pediatr Infect Dis J. 2017; 36:837–43.
crossref
26. LaCourse SM, Cranmer LM, Njuguna IN, Gatimu J, Stern J, Maleche-Obimbo E, et al. Urine tuberculosis lipoarabinomannan predicts mortality in hospitalized human immunodeficiency virus-infected children. Clin Infect Dis. 2018; 66:1798–801.
crossref
27. Portevin D, Moukambi F, Clowes P, Bauer A, Chachage M, Ntinginya NE, et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis. 2014; 14:931–8.
crossref
28. Sweeney TE, Braviak L, Tato CM, Khatri P. Genomewide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med. 2016; 4:213–24.
crossref
29. Huh S. Recent advances of medical journals in Korea and and further development strategies: is it possible for them to publish Nobel Prize-winning research? J Korean Med Assoc. 2018; 61:524–31. CROSSREF.
crossref
30. Nafade V, Nash M, Huddart S, Pande T, Gebreselassie N, Lienhardt C, et al. A bibliometric analysis of tuberculosis research, 2007–2016. PLoS One. 2018; 13:e0199706.
crossref

Fig. 1.
Flow chart of article selection.
piv-26-89f1.tif
Fig. 2.
Number of articles regarding pediatric and adolescent tuberculosis in Korea by time period.
piv-26-89f2.tif
Fig. 3.
Number of articles regarding pediatric and adolescent tuberculosis in Korea by journals.
piv-26-89f3.tif
Table 1.
Research areas and subject details of 82 original articles
Research areas Subject of articles No. of related articles
Clinical characteristics Pulmonary TB 8
  Miliary TB 6
  Tuberculous meningitis 6
  Childhood cancer patients 3
  Spinal TB 2
  Genitourinary TB 2
  Endobronchial TB 1
  Intracranial TB 1
  Fundus findings in TB 1
Diagnosis IGRA 11
  Comparison of IGRA and TST 4
  Adenosine deaminase 2
  Bronchoscopy 2
  TST 2
  Bacteriologic examination 1
  Peripheral-blood-based PCR assay 1
  Mass miniature radiography 1
Contact investigation   8
Epidemiology Drug-resistant TB 3
  Prevalence 1
  Molecular epidemiology 1
Treatment Rifampin effects 2
  Plaster-of-paris jackets 1
  Effects of chemoprophylaxis 1
Complication Spinal TB 2
  Growth change after knee joint TB 1
LTBI Risk factors 2
  Relationship between asthma 1
Knowledge and attitudes toward TB   2

Abbreviations: TB, tuberculosis; IGRA, interferon-gamma release assay; TST, tuberculin skin test; PCR, polymerase chain reaction; LTBI, latent tuberculosis infection.

TOOLS
Similar articles